Article Details

Priveterra Acquisition initial business combination with AEON Biopharma - Davis Polk

Retrieved on: 2022-12-14 19:10:01

Tags for this article:

Click the tags to see associated articles and topics

Priveterra Acquisition initial business combination with AEON Biopharma - Davis Polk. View article details on hiswai:

Excerpt

Davis Polk is advising Priveterra Acquisition Corp. on its acquisition of AEON Biopharma in exchange for the issuance of 16.5 million of shares of ...

Article found on: www.davispolk.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up